While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results. Adding Adcetris (brentuximab ...

Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B ...

Circulating tumor DNA (ctDNA) minimal residual disease (MRD) assessment at treatment completion provides superior prognostic accuracy compared with PET in large B-cell lymphoma. The CLARITY assay ...

A response-adapted approach to the treatment of patients with advanced Hodgkin's lymphoma de-escalates treatment after an early negative PET scan and intensifies treatment in those with a PET-positive ...

A positron emission tomography (PET) scan is an imaging technique that uses small amounts of radioactive substances. Doctors may use PET scans in chemotherapy treatments for cancer. PET scans help ...

PET scans use a radioactive tracer to generate images of the body for medical analysis. Doctors commonly use PET scans to detect cancer and assess how far it has spread. Radiation exposure from PET ...